These findings confirm the key role of SAMM50 in lipid metabolism and provide a mechanistic basis for SAMM50 polymorphisms associated with susceptibility to NAFLD. The gene discussed is SAMM50; the disease is metabolic dysfunction-associated steatotic liver disease.